Analyst consensus rating
Dyne Therapeutics Analyst Rating: Strong Buy
Direct answer
Dyne Therapeutics's consensus rating is Strong Buy.
15 analysts are included in the current consensus when a coverage count is available.
The same consensus reports an average price target of $36.00.
Forecast evidence checked October 27, 2026.
Get free Dyne Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $16.94
- Average price target
- $36.00
- High price target
- $50.00
- Low price target
- $10.00
- Low target gap
- -41%
- Target upside
- +112.5%
- High target gap
- +195.2%
- Target range width
- 236.1%
- Consensus rating
- Strong Buy
- Analysts
- 15
- Evidence date
- October 27, 2026
- Valid through
- November 3, 2026
Explore related company data
Read the frequently asked questions.
What is the analyst consensus rating for Dyne Therapeutics?
Dyne Therapeutics has a verified Strong Buy consensus. The same dataset has an average price target of $36.00.
How far are Dyne Therapeutics's low and high targets from the recorded price?
The low target implies -41%, while the high target implies +195.2%.
How many analysts are included in Dyne Therapeutics's consensus?
The verified consensus includes 15 analysts.
How is Dyne Therapeutics's target upside or downside calculated?
The average target of $36.00 is divided by the recorded price of $16.94, then one is subtracted to produce +112.5%. This does not guarantee a future return.
When was Dyne Therapeutics's analyst forecast verified?
The data was verified on 2026-10-27. The dataset is valid through 2026-11-03.